首页> 外文期刊>Gastroenterology research and practice >Self-Expanding Metal Stenting for Palliation of Patients with Malignant Colonic Obstruction: Effectiveness and Efficacy on 255 Patients with 12-Month's Follow-up
【24h】

Self-Expanding Metal Stenting for Palliation of Patients with Malignant Colonic Obstruction: Effectiveness and Efficacy on 255 Patients with 12-Month's Follow-up

机译:自膨胀金属支架置入术治疗恶性结肠梗阻患者:255例12个月随访患者的有效性和疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Self-expanding metal stents can alleviate malignant colonic obstruction in incurable patients and avoid palliative stoma surgery. Objective. Evaluate stent effectiveness and safety on palliation of patients with malignant colorectal strictures. Design. Two prospective, one Spanish and one global, multicenter studies. Settings. 39 centers (22 academic, 17 community hospitals) from 13 countries. Patients. A total of 257 patients were enrolled, and 255 patients were treated with a WallFlex uncovered enteral colonic stent. Follow-up was up to 12 months or until death or retreatment. Interventions(s). Self-expanding metal stent placement. Main Outcome Measures. Procedural success, clinical success, and safety. Results. Procedural success was 98.4% (251). Clinical success rates were 87.8% at 30 days, 89.7% at 3 months, 92.8% at 6 months, and 96% at 12 months. Overall perforation rate was 5.1%. Overall migration rate was 5.5%. Overall death rate during follow-up was 48.6% (124), with 67.7% of deaths related to the patient's colorectal cancer, unrelated in 32.3%. Only 2 deaths were related to the stent or procedure. Limitations. No control group. Conclusions. The primary palliative option for patients with malignant colonic obstruction should be self-expanding metal stent placement due to high rates of technical success and efficacy in symptom palliation and few complications.
机译:背景。自扩张式金属支架可以减轻无法治愈的患者的恶性结肠梗阻,并避免姑息性造口术。目的。评估支架对恶性大肠狭窄患者缓解疼痛的有效性和安全性。设计。两项前瞻性研究,一项是西班牙文,一项是全球性的多中心研究。设定来自13个国家的39个中心(22个学术机构,17个社区医院)。耐心。共有257位患者入组,其中255位患者接受了WallFlex揭露的肠结肠支架治疗。随访长达12个月,直至死亡或再次治疗。干预措施。自膨胀金属支架放置。主要观察指标。程序上的成功,临床上的成功和安全性。结果。手术成功率为98.4%(251)。 30天时临床成功率为87.8%,3个月时为89.7%,6个月时为92.8%,12个月时为96%。总体穿孔率为5.1%。总体迁移率为5.5%。随访期间的总死亡率为48.6%(124),其中67.7%的死亡与患者的结肠直肠癌有关,与之无关的占32.3%。仅2例死亡与支架或手术相关。局限性。没有对照组。结论恶性结肠梗阻患者的主要姑息治疗应是自扩张金属支架置入术,因为其技术成功率高,缓解症状的功效高且并发症少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号